Focus Partners Wealth
DNA icon

Focus Partners Wealth’s Ginkgo Bioworks DNA Stock Holding History

Focus Partners Wealth’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Sell
11,371
-471
-4% -$3.94K ﹤0.01% 2608
2026
Q1 		$72.6K Buy
11,842
+814
+7% +$6.77K ﹤0.01% 2551
2025
Q4 		$123K Buy
+11,028
New +$119K ﹤0.01% 2527

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Focus Partners Wealth's DNA Position: Q2 2026 in Review

Focus Partners Wealth reduced its Ginkgo Bioworks (DNA) stake by 4% in Q2 2026, selling an estimated $3.94K and leaving 11,371 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Focus Partners Wealth first reported a position in DNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $123K in Q4 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Focus Partners Wealth held 11,371 shares of Ginkgo Bioworks worth $113K as of Q2 2026.
  • Focus Partners Wealth sold 471 Ginkgo Bioworks shares in Q2 2026, an estimated $3.94K.
  • Ginkgo Bioworks made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2608 holding.
  • Focus Partners Wealth first reported a position in Ginkgo Bioworks in Q4 2025 and has held it in 3 quarters since.
  • Focus Partners Wealth's Ginkgo Bioworks position peaked at $123K in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.